瘤中的微生物群:影响癌症发展的新因素
Haixia Jiang1, Lan Li1, Yunxia Bao1
1Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cancer gene therapy
|September 28, 2024
概括
瘤微生物群,瘤内的微生物社区,越来越多地影响癌症的发展和进展. 了解这些微生物为癌症诊断和治疗提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 癌症研究 癌症研究
背景情况:
- 瘤微生物群领域正在迅速发展,揭示了瘤组织内的微生物群落.
- 微生物进入瘤的机制包括粘膜入侵,血液传播和肠-器官轴.
- 微生物可以通过调节免疫系统,炎症,新陈代谢和细胞入侵来影响癌症的进展.
研究的目的:
- 审查瘤微生物群研究的最新进展.
- 探索微生物迁移,致癌机制和瘤微生物的特征.
- 讨论向瘤微生物群在癌症治疗中的方法和临床应用.
主要方法:
- 高通量测序技术对于识别内微生物群落至关重要.
- 文献综述综合了关于瘤微生物群的当前知识.
- 分析微生物在癌症病原和治疗潜力的作用.
主要成果:
- 越来越多的证据支持微生物在瘤中的存在和影响.
- 瘤微生物群可以通过各种机制促进癌症的发展和进展.
- 向瘤微生物群为新的诊断和治疗策略提供了潜力.
结论:
- 瘤微生物群在癌症发病过程中起着重要作用.
- 对微生物机制的进一步研究可以导致新的癌症预防和治疗策略.
- 对瘤微生物群的研究在瘤学中提供了一个有前途的前沿.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


